TCL Archive Abraxane Improves Progression-Free Survival Compared to Decarbazine In Stage IV Disease November 30, 2012
TCL Archive Also NCI appoints members of Clinical Trials Working Group to review trials system. January 9, 2004
TCL Archive NCI Study Fails To Support Finding Of Excess Cancer In Utah Nuclear Fallout Areas January 23, 1987
TCL Archive Also in this 8-page issue: American Legacy Foundation calls Time Inc. a “hero” of tobacco control, but antismoking activists see villain. Time Inc. and parent Time Warner hasn’t made progress in reducing tobacco advertising in magazines, movies, researchers say. March 4, 2005
TCL Archive Hard imes For Cancer Control – Six Contracts Ended; Rochester’s Community Proposal Rejected October 1, 1976
